CAMBRIDGE, Mass.--(BUSINESS WIRE)--Semma Therapeutics, Inc., a biotechnology company pioneering the curative use of stem cells in regenerative medicine, today announced the achievement of pre-clinical ...

Erika Adams is the former deputy editor of Eater’s Northeast region, where she covered Boston, Philly, D.C. and New York. Based in Boston, she has spent years covering the local restaurant industry.

The New York Times has unveiled its list of the 100 Best Restaurants in New York City for 2026, and this year's selection ...

Semma Therapeutics has raised $114 million to take a potentially-curative Type 1 diabetes cell therapy through clinical proof of concept. The round positions Semma to start learning whether its ...

Let’s start with a trivia question. How many Indian restaurants in the United States have a Michelin star? Is it five? 10? Two years ago, there was just one: Semma, a south Indian restaurant in New ...

CAMBRIDGE, Mass. – Semma Therapeutics, a company developing a cell therapy for Type 1 diabetes, announced today that it has closed a $44 million Series A consisting of equity financing and strategic ...

Nadia Chaudhury is a born-and-raised New Yorker who is the deputy editor for Eater’s Northeast region and Eater New York, was the former Eater Austin editor for 10 years, and often writes about food ...

A startup that wants to change the way we treat type 1 diabetes just raised $114 million. Semma Therapeutics, a company that got its start in 2014, is researching ways to use stem cells that act like ...

Director Pandiraj who gave us the hit Pasanga (2009), is lauching his former assistant Vallikanth as a director with the GV Prakash-starrer Semma. “Almost every assistant of mine is a filmmaker today.

Semma Therapeutics, a company developing a cell therapy for Type 1 diabetes, announced today that it has closed a $44 million Series A consisting of equity financing and strategic funding. The Series ...